Cheng Zhang is the founder of Character Biosciences. Character Biosciences has raised $128M in total funding. Latest round: Series B.
Cheng Zhang is the Co-founder and CEO of Character Biosciences, a San Francisco-based precision medicine company. He led the rebranding of the company from Clover Therapeutics in 2022. He has secured significant funding rounds to advance therapies for age-related macular degeneration (AMD).
Full founder directory · Investor directory · Company funding database · Fundraising library